搜索临床试验以:Z-521
总计2002个结果
-
National Cancer Institute (NCI)主动,不招人复发性套细胞淋巴瘤 | 复发性边缘区淋巴瘤 | 复发性弥漫性大 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 | 难治性套细胞淋巴瘤 | 复发性滤泡性淋巴瘤 | 难治性滤泡性淋巴瘤 | 难治性边缘区淋巴瘤 | 复发性淋巴浆细胞性淋巴瘤 | 难治性淋巴浆细胞性淋巴瘤美国, 加拿大
-
Roswell Park Cancer Institute招聘中
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)完全的
-
Harvard School of Public Health (HSPH)National Institute of Allergy and Infectious Diseases (NIAID)终止
-
AJU Pharm Co., Ltd.招聘中
-
University of California, San Francisco完全的
-
Children's Oncology GroupNational Cancer Institute (NCI)主动,不招人复发性神经母细胞瘤 | 难治性神经母细胞瘤 | 高危神经母细胞瘤美国, 加拿大, 波多黎各, 澳大利亚, 新西兰
-
Mayo ClinicNational Cancer Institute (NCI)完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
M.D. Anderson Cancer CenterNovartis Pharmaceuticals完全的
-
National Cancer Institute (NCI)United Therapeutics完全的
-
Children's Oncology GroupNational Cancer Institute (NCI)完全的
-
Freeman-Sheldon Research Group, Inc.撤销
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)招聘中
-
University of North Carolina, Chapel Hill完全的
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
Thomas Jefferson UniversityNational Cancer Institute (NCI)招聘中复发性边缘区淋巴瘤 | 难治性 B 细胞非霍奇金淋巴瘤 | 复发性 B 细胞非霍奇金淋巴瘤 | 难治性惰性成人非霍奇金淋巴瘤 | 复发性滤泡性淋巴瘤 | 难治性滤泡性淋巴瘤 | 难治性边缘区淋巴瘤 | 复发性惰性成人非霍奇金淋巴瘤美国
-
National Cancer Institute (NCI)Celgene Corporation主动,不招人Ann Arbor III 期 1 级滤泡性淋巴瘤 | Ann Arbor III 期 2 级滤泡性淋巴瘤 | Ann Arbor IV 期 1 级滤泡性淋巴瘤 | Ann Arbor IV 期 2 级滤泡性淋巴瘤 | Ann Arbor II 期 3 级连续性滤泡性淋巴瘤 | Ann Arbor II 期 3 级非连续性滤泡性淋巴瘤 | Ann Arbor III 期 3 级滤泡性淋巴瘤 | Ann Arbor IV 期 3 级滤泡性淋巴瘤 | Ann Arbor II 期 1 级连续性滤泡性淋巴瘤 | Ann Arbor II 期 1 级非连续性滤泡性淋巴瘤 | Ann Arbor II 期 2 级连续性滤泡性淋巴瘤 | Ann Arbor...美国
-
National Cancer Institute (NCI)Radiation Therapy Oncology Group; American College of Radiology Imaging Network完全的
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)招聘中
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Incyte Corporation; Ipsen; BeiGene招聘中复发性弥漫性大 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 | 高级别 B 细胞淋巴瘤 | 3b 级滤泡性淋巴瘤 | 转化的非霍奇金淋巴瘤 | 具有 MYC 和 BCL2 和/或 BCL6 重排的高级别 B 细胞淋巴瘤美国
-
University of California, San FranciscoMerck Sharp & Dohme LLC; Gilead Sciences; National Institutes of Health (NIH); Abbott完全的
-
International Maternal Pediatric Adolescent AIDS...National Institute of Allergy and Infectious Diseases (NIAID)完全的
-
Mayo Clinic主动,不招人
-
Mayo ClinicNational Cancer Institute (NCI)终止
-
University of BrasiliaMinistry of Health, Brazil; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Ministry... 和其他合作者完全的
-
Respirent Pharmaceuticals Co Ltd.Becro Ltd.完全的
-
University of Southern CaliforniaNational Cancer Institute (NCI); Amgen终止IV 期结直肠癌 AJCC v7 | IVA 期结直肠癌 AJCC v7 | IVB 期结直肠癌 AJCC v7 | 结直肠腺癌 | RAS 野生型 | III 期结直肠癌 AJCC v7 | IIIA 期结直肠癌 AJCC v7 | IIIB 期结直肠癌 AJCC v7 | IIIC 期结直肠癌 AJCC v7美国
-
International Research Training Group 2804German Research Foundation; Uppsala University; University Hospital Tuebingen招聘中
-
International Research Training Group 2804German Research Foundation; University Hospital Tübingen; Werner Reichardt Centrum für Integrative...完全的
-
Therapeutic Advances in Childhood Leukemia ConsortiumPfizer完全的
-
Children's Oncology Group主动,不招人淋巴母细胞淋巴瘤 | 急性白血病 | 复发性疾病 | T细胞淋巴瘤 | 白血病,淋巴细胞 | T细胞白血病美国
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)NRG Oncology; Radiation Therapy Oncology Group完全的
-
Children's Oncology Group尚未招聘复发性急性髓性白血病 | 复发性骨髓增生异常综合征 | 难治性急性髓性白血病 | 难治性骨髓增生异常综合征 | 复发性幼年粒单核细胞白血病 | 难治性幼年型粒单核细胞白血病